NADAM 2017
Home | News | Events | Press | Contact  

About UseNewsletterMessage BoardsAction CenterAdvocateWalk to End Alzheimer’sShopDonate

Find your chapter:

search by state

Current News Releases
Text Size controlsNormal font sizeMedium font sizeLarge font size

 

November 13, 2017
The Alzheimer's Association Welcomes Bill Gates to the Trenches to Dig Deep into the Alzheimer's Disease
Today Bill Gates announced his commitment to the Alzheimer's cause. The Alzheimer's Association welcomes him and applauds his efforts to seek an end to Alzheimer's, which he details in the piece titled "Why I'm Digging Deep into Alzheimer's." As he notes, more people are living longer than ever before and discoveries in science mean that less people die young from heart disease, cancer and infectious disease, allowing for longer lives. However, along with increased age comes a greater risk of developing Alzheimer's, a disease that is not normal aging and is ultimately fatal.

November 8, 2017
Alzheimer’s Association and Alzheimer’s Impact Movement statement on the Tax Cuts and Jobs Act
The Alzheimer’s Association and Alzheimer's Impact Movement (AIM) are deeply concerned by the removal of the medical expense deduction in the Tax Cuts and Jobs Act released in the House of Representatives. Families rely on this tax deduction to offset the high costs associated with the long-term care required by Alzheimer’s and related dementia.

November 6, 2017
The Building Our Largest Dementia (BOLD) Infrastructure Act introduced in House and Senate
The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) are proud to support the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act, new bipartisan legislation prioritizing our nation’s approach to Alzheimer’s disease.

October 24, 2017
Innovative Alzheimer's disease combination therapy trial supported by new joint funding initiative
The Alzheimer's Association and Alzheimer's Drug Discovery Foundation (ADDF) are collaborating to jointly fund a new combination therapy clinical trial for Alzheimer's disease to be conducted by Amylyx Pharmaceuticals. The $1.85 million grant is the first award under an initiative created by the Alzheimer's Association and the ADDF to fund combination therapies.

September 28, 2017
Robert Egge named to National Alzheimer's Project Act Advisory Council
Today, the Department of Health and Human Services (HHS) announced the appointment of Robert Egge to the National Alzheimer’s Project Act (NAPA) Advisory Council. Egge serves as the chief public policy officer of the Alzheimer’s Association and the executive director of the Alzheimer’s Impact Movement (AIM), the Association’s advocacy arm.

September 20, 2017
Alzheimer's Association and Alzheimer's Impact Movement statement on the Graham-Cassidy Amendment
Across the country, millions of Americans living with Alzheimer's or other dementias rely on Medicaid services to access quality care. The Alzheimer's Association and Alzheimer's Impact Movement (AIM) are therefore troubled by elements of the proposed Graham-Cassidy Amendment and the impact it may have on this population.

September 15, 2017
Alzheimer's Association, National Hispanic Council on Aging collaborate to educate Latino communities about Alzheimer's, increase access to information and resources
The Alzheimer's Association and the National Hispanic Council on Aging (NHCOA) announced today a nationwide partnership aimed at increasing Alzheimer's disease awareness and education in Latino communities across the country.

Spanish version

September 7, 2017
Senate Appropriations Committee renews commitment to Alzheimer's research funding
The Senate Appropriations Committee has approved an additional $414 million increase for Alzheimer’s and dementia research for the fiscal year 2018 budget. The Alzheimer’s Association, the Alzheimer’s Impact Movement (AIM) and our network of advocates applaud the Senate Appropriations Committee for approving this important funding increase.

September 6, 2017
Senate Labor-HHS Appropriations Subcommittee advances increase to Alzheimer's research funding
Today, the Senate Appropriations Labor, Health and Human Services, Education and Related Agencies (Labor-HHS) Subcommittee proposed a $414 million increase for Alzheimer’s research at the National Institutes of Health (NIH) for fiscal year 2018. This announcement comes following similar action by the House Appropriations Committee in July. The Senate Appropriations Committee is expected to act on the funding bill next week.

August 16, 2017
Department of Defense to cover care planning for people living with Alzheimer's and other dementias through TRICARE
The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) applaud the Department of Defense’s announcement that TRICARE, a health care plan for uniformed service members and their families, will now cover care planning for people living with Alzheimer’s and other dementias.

August 15, 2017
Alzheimer's Association mourns death of legendary football coach and Alzheimer's advocate Frank Broyles
The Alzheimer’s Association extends sincere condolences to the family of Coach Frank Broyles following his death due to complications of Alzheimer’s. Coach Broyles was a legendary leader on the field, and the Association saw that leadership translate off the field as he became a dedicated Alzheimer’s advocate later in life. He bravely shared his personal experience as a caregiver for his wife, Barbara, who battled Alzheimer’s disease.

August 8, 2017
Alzheimer's Association mourns death of country music legend Glen Campbell
The Alzheimer’s Association is saddened by the death of country music legend Glen Campbell. He and his family bravely revealed his Alzheimer’s diagnosis in 2011, and embarked on a final “Goodbye Tour” that was documented in the award-winning documentary “I’ll Be Me.”

July 19, 2017
Alzheimer's research funding receives continued strong bipartisan support in House
Today, the House Appropriations Committee approved an additional $400 million increase for Alzheimer’s and dementia research for the fiscal year 2018 budget. If signed into law, this would be in addition to the $400 million increase signed into law in May for fiscal year 2017.

July 12, 2017
House Appropriations Subcommittee proposes additional substantial increase in Alzheimer's research funding
The House Appropriations Labor, Health and Human Services, Education and Related Agencies Subcommittee proposed a $400 million increase for Alzheimer's research at the National Institutes of Health (NIH) for fiscal year 2018. If signed into law, this would be in addition to the $400 million increase signed into law in May for fiscal year 2017. Read the joint statement from the Alzheimer's Association and the Alzheimer's Impact Movement.

June 23, 2017
Alzheimer’s Association and Alzheimer’s Impact Movement Statement on the Better Care Reconciliation Act
The Alzheimer’s Association and Alzheimer's Impact Movement (AIM) are deeply concerned by provisions in the proposed health care reform bill released in the Senate.

June 8, 2017
IDEAS Study spurs related research to impact dementia care
The milestone Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) Study is working with government and academic researchers to launch three add-on studies to expand the impact of the core study where more than 18,000 people with cognitive decline but an unclear diagnosis will receive an amyloid PET scan.

June 1, 2017
New Alzheimer’s Association survey reveals dramatic impact of Alzheimer’s disease on families
New findings from an Alzheimer’s Association survey, released today in conjunction with the beginning of Alzheimer’s & Brain Awareness Month, show that while people overwhelmingly agree it often takes a village to provide care for someone living with Alzheimer’s or another form of dementia (91 percent), far too many caregivers are doing it alone.

May 11, 2017
Bipartisan Legislation to Provide Necessary Support Services to Alzheimer’s Family Caregivers Introduced in Senate
The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) announced its support for the bipartisan Recognize, Assist, Include, Support, and Engage (RAISE) Family Caregivers Act (S. 1028).

May 10, 2017
Alzheimer’s Association and Alzheimer’s Impact Movement Statement on Health Care Reform
As Congress considers options related to the Affordable Care Act, the Alzheimer’s Association and Alzheimer's Impact Movement (AIM) will evaluate proposals based on how they are likely to impact people living with Alzheimer’s and other dementias and their caregivers.

May 5, 2017
Alzheimer’s Association and Alzheimer’s Impact Movement lead the way to $400 million federal research increase
Today, a $400 million increase in Alzheimer’s disease research funding was signed into law, increasing federal funding at the National Institutes of Health (NIH) to nearly $1.4 billion.

May 1, 2017
Congress delivers historic Alzheimer's research funding increase for second consecutive year
The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) are celebrating the announcement that Congress will pass a $400 million increase for Alzheimer’s research funding at the National Institutes of Health (NIH) in the FY2017 budget.

March 22, 2017
Palliative Care and Hospice Education and Training Act (PCHETA) introduced in Congress
The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) support the Palliative Care and Hospice Education and Training Act (PCHETA). Reintroduced by Sen. Tammy Baldwin (D-Wisc.), Sen. Shelley Moore Capito (R-W.Va.), Rep. Eliot Engel (D-N.Y.) and Rep. Tom Reed (R-N.Y.). PCHETA would ensure an adequate, well-trained palliative care workforce through workforce training, education and awareness, and enhanced research.

March 22, 2017
Alzheimer’s Association and Alzheimer’s Impact Movement statement on Medicaid reform proposals
The Alzheimer’s Association and the Alzheimer’s Impact Movement are concerned about recent proposals to overhaul Medicaid. Medicaid’s commitment to institutional care is critical for those living with Alzheimer’s and other dementias and should be preserved through any proposed changes to the Medicaid program.

March 16, 2017
Alzheimer's Association new interactive LiveWell series offers online tools to empower people to live well with dementia
The Alzheimer's Association announced today new online resources to help those in the early stage of Alzheimer's disease or other dementias to live well. The Association's new LiveWell resources offer interactive tools, including video insights from those living with the disease, to help users navigate the personal and emotional challenges that accompany an Alzheimer's diagnosis.

March 07, 2017
New Alzheimer's Association report shows growing cost and impact of Alzheimer's disease on nation's families and economy
For the first time, total payments exceeded a quarter of a trillion dollars ($259 billion) for caring for individuals living with Alzheimer's or other dementia, according to data reported in 2017 Alzheimer's Disease Facts and Figures, released today by the Alzheimer's Association.

Alzheimer's Association special report highlights advances in research leading to the next frontier in Alzheimer's disease diagnosis and treatment
The Alzheimer's Association today released the 2017 Alzheimer's Disease Facts and Figures special report that highlights the growing importance of biomarkers in improving how we identify and diagnose Alzheimer's disease.

March 02, 2017
STATEMENT: Re: Reuters Article Titled: "Industry ties common among nonprofit patient advocacy groups"
In a Reuters article originally published on March 1, 2017 the Alzheimer's Association was incorrectly referenced. For further clarity, please reference the full statement.

January 17, 2017
Study finds high blood pressure onset later in life may protect against dementia
New study results published online today in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association suggest that onset of high blood pressure later in life is associated with lower dementia risk after age 90, especially if hypertension is developed at age 80 or older.


December 7, 2016
Congress passes 21st Century Cures Act to advance innovative medical research for Alzheimer's, other diseases
Today, the Alzheimer's Association is celebrating the passage of the 21st Century Cures Act, important legislation that supports health care innovation to accelerate the discovery, development and delivery of new treatments and cures for all diseases, including Alzheimer's and other dementias.

November 23, 2016
Eli Lilly announces negative results from Phase III study of solanezumab
Eli Lilly announced that a Phase III study (EXPEDITION3 trial) of the anti-amyloid drug solanezumab in people with mild Alzheimer’s did not find a statistically significant slowing of cognitive decline in treated patients versus those who received placebo. The Alzheimer’s Association is disappointed with the negative results of this clinical trial and hopes that ongoing Alzheimer's prevention trials testing the drug will continue.

November 22, 2016
JAMA Internal Medicine article reports reduction in U.S. dementia prevalence rate
A new JAMA Internal Medicine article reports a reduction in the percentage of older people with dementia between 2000 and 2012. These findings, in addition to other similar studies and ​data published in the Alzheimer's Association Alzheimer's Disease Facts and Figures report, strongly suggest that risk for dementia can be reduced. However, there is an important difference between prevalence rate and prevalence number, which the Alzheimer's Association believes is still increasing.

November 14, 2016
Alzheimer's Association ready to work with new administration and new Congress
The Alzheimer’s Association is ready for the next stage of advancing public policy to improve the lives of the more than 5 million Americans living with Alzheimer’s disease and their 15 million caregivers, working collaboratively with the Trump administration and the 115th Congress.

November 3, 2016
Medicare to provide coverage for critical care and support services for individuals living with Alzheimer's disease
The Centers for Medicare & Medicaid Services (CMS) has finalized its decision to pay for cognitive and functional assessments and care planning for people living with Alzheimer's disease and other cognitive impairments. For the first time, people living with Alzheimer's will have access to care planning with a medical professional.

October 3, 2016
Alzheimer's Association mourns the death of researcher Allen Roses, M.D.
The Alzheimer's Association is saddened to learn of the death of pioneering researcher Allen Roses, M.D. Roses was a visionary and innovator in the fields of neurology, genetics and drug development.

Alzheimer's Association mourns the death of researcher Dale Schenk, Ph.D.
The Alzheimer's Association is saddened to learn of the death of scientist Dale Schenk, Ph.D., who devoted his career to researching brain diseases such as Alzheimer's and Parkinson's.

August 30, 2016
Alzheimer's Association accelerates research on potential sex differences in Alzheimer's
The first-ever Alzheimer's Association Sex and Gender in Alzheimer's (SAGA) research grant awards will provide $2.2 million to nine projects to advance understanding of the disproportionate effect of Alzheimer's disease on women.

August 29, 2016
Study examines relationship between PTSD and cognitive impairment in World Trade Center responders
New research published by the journal Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring confirms the connection between posttraumatic stress disorder (PTSD) and cognitive impairment — in this case, among those who helped with search, rescue and cleanup efforts following the 2001 World Trade Center attacks.

August 9, 2016
Second Alzheimer's professional judgment budget reflects urgent need to find a cure or treatment
The National Institutes of Health (NIH) recommended in its second-ever professional judgment budget for Alzheimer’s research a $414 million increase for FY2018 annual spending “to meet one of the greatest challenges of our time ― the development of effective treatments for and prevention of Alzheimer’s and related dementias by 2025.”

August 2, 2016
Alzheimer's Association issues $7 million challenge to scientists to speed drug discovery
The Alzheimer’s Association, in partnership with a fundraising initiative led by philanthropist Michaela “Mikey” Hoag, announced a new $7 million investment in clinical trials that target brain inflammation as an innovative avenue for Alzheimer’s disease therapy.

July 20, 2016
Sigma Kappa supports Alzheimer's Association with $1 million gift
Sigma Kappa Foundation presented the Alzheimer's Association with the $1 million lead gift for the Women's Alzheimer's Research Initiative at Sigma Kappa's 87th National Convention held in Chicago. The gift will fund innovative research focused on women including studies to understand why more women are living with this disease and studies led by female researchers working to advance Alzheimer's and dementia science.

July 14, 2016
Alzheimer’s research funding receives bipartisan support in House
Today, the House Appropriations Committee approved an additional $350 million for Alzheimer’s disease research. The Alzheimer’s Association, the leading advocate for federal Alzheimer’s disease research funding and caregiver support, and its advocates applaud the bipartisan action of the House Appropriations Committee to approve a significant increase for Alzheimer’s disease research funding at the NIH.

July 13, 2016
Alzheimer’s Association advocate shares personal experience and urges Congress to increase support for caregivers
Speaking on behalf of the more than 15 million Americans providing care to the more than 5 million Americans living with Alzheimer’s, Alzheimer’s Association advocate Connie Bastek-Karasow urged Congress to work to improve the Medicare system to provide better care for American families facing this diagnosis until a scientific breakthrough leads to an effective treatment or cure for the disease.

July 12, 2016
Alzheimer’s Association celebrates milestone for care and support services announced by CMS
Following rapidly growing bipartisan support in Congress for the Health Outcomes, Planning, and Education (HOPE) for Alzheimer’s Act, the Centers for Medicare & Medicaid Services (CMS) has proposed to begin paying for cognitive and functional assessment and care planning for people with Alzheimer’s disease and other cognitive impairments.

July 6, 2016
House hears the call of Alzheimer’s Association advocates, proposes critical research funding increase
Today, the House Labor-HHS Appropriations Subcommittee proposed a $350 million increase for Alzheimer’s research at the NIH. This bipartisan effort was led by Alzheimer’s champion Chairman Tom Cole (R-Okla.) and comes just weeks after the Senate Appropriations Committee proposed a historic $400 million increase.

June 26, 2016
Alzheimer's Association mourns death of legendary basketball coach Pat Summitt
The Alzheimer's Association was saddened to learn about the death of legendary basketball coach Pat Summitt. Already a trailblazer, becoming the winningest Division 1 coach in NCAA history, Coach Summitt led the way by bravely disclosing her younger-onset Alzheimer's diagnosis in May 2011.

June 9, 2016
Alzheimer's Association celebrates extraordinary week
Today, the Senate Appropriations Committee approved a $400 million increase in Alzheimer's disease research funding at the NIH and included the Health Outcomes, Planning, and Education (HOPE) for Alzheimer's Act in its funding bill. The Alzheimer's Association applauds the committee for this momentous action in the journey to end the Alzheimer's epidemic — and in improving support for those who face the disease today.

June 7, 2016
Senate makes monumental commitment to care and support
Today, the Alzheimer’s Association and its relentless advocates, applaud the Senate Labor-HHS Appropriations Subcommittee for its commitment to the more than 5 million Americans living with Alzheimer’s disease and their more than 15 million caregivers. In a bipartisan effort, the committee included the Health Outcomes, Planning, and Education (HOPE) for Alzheimer’s Act (S. 857) in its funding bill. Since its inception, the Alzheimer’s Association has been intricately involved with its creation and strongly endorsed the HOPE for Alzheimer’s Act upon introduction by Senator Debbie Stabenow (D-MI).

June 6, 2016
Alzheimer's research funding on path for additional $400 million increase
Today, the call for increased Alzheimer's research funding from Alzheimer's Association advocates reached a critical milestone, as the Senate Labor-HHS Appropriations Subcommittee announced a proposed $400 million increase for Alzheimer's research at the NIH. This bipartisan effort was led by Alzheimer's champions Chairman Roy Blunt (R-Mo.) and Ranking Member Patty Murray (D-Wash.), who also oversaw last year's historic funding increase.

June 1, 2016
"Uncovering the truth about Alzheimer's" confronts damaging myths about the disease
To improve the public’s understanding of Alzheimer's and to underscore the need for swift action, the Alzheimer’s Association is highlighting essential truths aimed at curbing common misconceptions about the disease during Alzheimer's & Brain Awareness Month in June.

April 29, 2016
The Alzheimer’s Association responds to news that film under development would depict President Ronald Reagan's dementia as a comedic device
The Alzheimer’s Association is appalled that anyone would plan to develop a film that satirizes an individual living with Alzheimer's or another dementia.

April 23, 2016
Alzheimer's Association awards $4.3 million to accelerate the launch of new drug treatment arms in landmark prevention trial
The Alzheimer's Association announces a new $4.3 million research grant for a new phase of the Dominantly Inherited Alzheimer's Network Trials Unit (DIAN-TU) known as DIAN-TU Next Generation (NexGen). This award will accelerate the testing of new potential Alzheimer's therapies and a new diagnostic approach in people with genetically based, younger-onset Alzheimer's disease using an innovative trial design that is being applied to Alzheimer's for the first time.

April 13, 2016
Bipartisan Legislation Offering Critical Support for Older Americans Passes in Senate, House
The Alzheimer’s Association and its nationwide network of advocates celebrate the passage of the Older Americans Act (OAA) Reauthorization Act of 2016.

April 6, 2016
David Hyde Pierce Shares Personal Experience with Alzheimer's, Urges Congress to Increase Support for Caregivers
Emmy Award-winning actor David Hyde Pierce today praised Congress for its continued commitment to increasing research funding for Alzheimer's and called for additional funding for research and similar progress supporting people with Alzheimer's disease and their families.

April 6, 2016
Alzheimer's Association Applauds Introduction of Palliative Care and Hospice Education and Training Act
The Alzheimer's Association and its nationwide network of advocates strongly supports the Palliative Care and Hospice Education and Training Act (PCHETA) (S.2748), introduced in the Senate by Senator Tammy Baldwin (D-WI).

March 30, 2016
Alzheimer's Association report shows care contributors sacrifice own food and medical care to support person with Alzheimer's disease
The personal financial support required by a person with Alzheimer's disease may ultimately deprive care contributors of basic necessities, such as food, transportation and medical care, according to the 2016 Alzheimer's Disease Facts and Figures report released today.

March 6, 2016
Alzheimer's Association mourns death of former first lady and Alzheimer's disease champion
The Alzheimer's Association was saddened to learn of the passing of former first lady and Alzheimer's advocate, Nancy Reagan. Mrs. Reagan was a long-standing honorary member of the Alzheimer's Association National Board of Directors and her involvement in the cause inspired the Alzheimer's community of families, caregivers and researchers.

March 2, 2016
Patient enrollment opens for largest brain amyloid scanning research study
Participating dementia specialists may now enroll patients to participate in the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study at IDEAS-Study.org. Primary care and other doctors not taking part in the IDEAS Study are encouraged to refer eligible patients to participating physicians.

February 25, 2016
Alzheimer's Association participates in global leadership of the World Dementia Council
While the Alzheimer's Association and its counterparts in other nations are on the front lines of this epidemic, we cannot do it alone. Governments and industry must be actively engaged and all those affected must raise their voices, illustrating the importance of the World Dementia Council (WDC).

February 16, 2016
Alzheimer's Association and Edward Jones partner to change the course of Alzheimer's for millions
The Alzheimer's Association today announced a historic partnership with St. Louis-based financial services firm Edward Jones. which has committed $4.7 million over two years to support the Association's mission.

February 10, 2016
Landmark study finds U.S. dementia incidence highest in African-Americans and American Indians
The first study to look at dementia risk in a population representing the diversity of the United States finds dementia incidence to be highest in African-Americans and lowest in Asian-Americans.


 

Alzheimer's Association

Our vision: A world without Alzheimer's disease®.
Formed in 1980, the Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research.